DNA Methylation Variability Could Revolutionize Cancer Care?

Others are taking sides. United States hasn't spoken yet.

Saint Pierre and Miquelon is leading 'The discovery of DNA methylation variability offers a new path to more accurate and tailored treatments for millions suffering from various cancers. This could drastically improve patient outcomes, reducing reliance on generic chemotherapy drugs that often do little good.', while Botswana stands for 'While promising in theory, the practical application may be years away due to complex regulatory hurdles and high costs of implementation, leaving current cancer patients with few immediate benefits.'. United States... this is still ours to define.